Peter Barrett, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 341,549 shares at $15.98 ($5.4M) on 2006-02-28, disclosed to the SEC on 2006-03-01.
Open-market sale of $5.4M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.77 | 1,316 | $21K | 0.4% |
| 2 | $15.77 | 2,627 | $41K | 0.8% |
| 3 | $15.77 | 3,875 | $61K | 1.1% |
| 4 | $15.77 | 19,638 | $310K | 5.7% |
| 5 | $15.77 | 79,047 | $1.2M | 23.1% |
| 6 | $15.77 | 143,497 |
| $2.3M |
| 41.9% |
| 7 | $15.98 | 482 | $8K | 0.1% |
| 8 | $15.98 | 962 | $15K | 0.3% |
| 9 | $15.98 | 1,419 | $23K | 0.4% |
| 10 | $15.98 | 7,191 | $115K | 2.1% |
| 11 | $15.98 | 28,947 | $463K | 8.6% |
| 12 | $15.98 | 52,548 | $840K | 15.5% |
| Total | $15.83 avg | 341,549 | $5.4M | 100% |
| Filing → |
| PKI | SELL | 2017-11-14 | $1.0M | — | Filing → |
| PKI | SELL | 2017-06-02 | $632K | — | Filing → |
| VTAE | BUY | 2014-10-01 | $300K | — | Filing → |